The European Medicines Agency (EMA) is the European Union regulatory authority that evaluates, supervises, and monitors medicines across member states.
EMA guidance influences clinical trial design, safety reporting requirements, and data standards for studies intended to support EU approvals. Sponsors running global programs often harmonize protocols to meet EMA and FDA expectations to avoid rework and support simultaneous submissions. EMA oversight includes assessment of benefitñrisk, pharmacovigilance planning, and post-authorization commitments. Understanding EMA requirements is essential for multinational trial strategy and regulatory alignment.